Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gagne

Showing results (51-60 of 344) with videos related to

Pageof 35
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Beta-blocker initiation and adherence after hospitalization for acute myocardial infarctionVittorio Maio, Massimiliano Marino, Mary Robeson, et al.
British Journal of Clinical Pharmacology|June 5, 2018
Identifying signals of interest when screening for drug-outcome associations in health care dataAnton Pottegård, Jesper Hallas, Shirley V Wang, et al.
Pharmacotherapy|August 24, 2017
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney DiseaseRishi J Desai, Julia Spoendlin, Helen Mogun, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction β-Blocker Utilization, Adherence, and RehospitalizationKatsiaryna Bykov, Joshua J Gagne, Bo Wang, et al.
Epidemiology (Cambridge, Mass.)|August 21, 2019
Comparison of Self-controlled Designs for Evaluating Outcomes of Drug-Drug Interactions: Simulation StudyKatsiaryna Bykov, Jessica M Franklin, Hu Li, et al.
American Journal of Epidemiology|August 3, 2014
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designsShirley V Wang, Sebastian Schneeweiss, Malcolm Maclure, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2016
Confounding of the association between statins and Parkinson disease: systematic review and meta-analysisKatsiaryna Bykov, Kazuki Yoshida, Marc G Weisskopf, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Developing alerting thresholds for prospective drug safety monitoringGrace Wangge, Sebastian Schneeweiss, Robert J Glynn, et al.
Clinical Pharmacology and Therapeutics|July 16, 2010
Refilling and switching of antiepileptic drugs and seizure-related eventsJ J Gagne, J Avorn, W H Shrank, et al.
The International Journal of Lower Extremity Wounds|March 18, 2006
Minimally invasive revascularization strategies for chronic lower limb ischemiaBart E Muhs, Paul J Gagne, Thomas Maldonado, et al.
Pageof 35

Showing results (51-60 of 344) with videos related to

Sort By:
Pageof 35
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Beta-blocker initiation and adherence after hospitalization for acute myocardial infarctionVittorio Maio, Massimiliano Marino, Mary Robeson, et al.
British Journal of Clinical Pharmacology|June 5, 2018
Identifying signals of interest when screening for drug-outcome associations in health care dataAnton Pottegård, Jesper Hallas, Shirley V Wang, et al.
Pharmacotherapy|August 24, 2017
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney DiseaseRishi J Desai, Julia Spoendlin, Helen Mogun, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction β-Blocker Utilization, Adherence, and RehospitalizationKatsiaryna Bykov, Joshua J Gagne, Bo Wang, et al.
Epidemiology (Cambridge, Mass.)|August 21, 2019
Comparison of Self-controlled Designs for Evaluating Outcomes of Drug-Drug Interactions: Simulation StudyKatsiaryna Bykov, Jessica M Franklin, Hu Li, et al.
American Journal of Epidemiology|August 3, 2014
"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designsShirley V Wang, Sebastian Schneeweiss, Malcolm Maclure, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2016
Confounding of the association between statins and Parkinson disease: systematic review and meta-analysisKatsiaryna Bykov, Kazuki Yoshida, Marc G Weisskopf, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Developing alerting thresholds for prospective drug safety monitoringGrace Wangge, Sebastian Schneeweiss, Robert J Glynn, et al.
Clinical Pharmacology and Therapeutics|July 16, 2010
Refilling and switching of antiepileptic drugs and seizure-related eventsJ J Gagne, J Avorn, W H Shrank, et al.
The International Journal of Lower Extremity Wounds|March 18, 2006
Minimally invasive revascularization strategies for chronic lower limb ischemiaBart E Muhs, Paul J Gagne, Thomas Maldonado, et al.
Pageof 35